| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $1.14B | +14.3% |
| Gross profit | $0.72B | — |
| Operating income | $0.36B | — |
| Net income | $0.28B | +14.7% |
| Gross margin | 63.4% | Net margin 24.4% |
| Segment | Revenue | Share |
|---|---|---|
| Vet Lab Consumables | $0.41B | 36.2% |
| Reference Laboratory Diagnostic And Consulting Services | $0.39B | 33.9% |
| Rapid Assay Products | $0.08B | 7.4% |
| Recurring Revenue | $0.07B | 6.4% |
| CAGDiagnostic Capital Instruments | $0.04B | 3.7% |
| CAGDiagnostics Service And Accessories | $0.04B | 3.2% |
| Systems And Hardware | $0.02B | 1.6% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $0.42B | 36.6% |
| R&D | $0.07B | 5.8% |
| Tax & other | $0.08B | 7.4% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
ITW ・ INCY ・ IR ・ PODD ・ INTC ・ IBKR ・ ICE ・ IFF ・ IP ・ INTU ・ ISRG ・ IVZ
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies